ClinicalTrials.Veeva

Menu

Efficacy and Safety of Retrograde Intraarticular Injection, Topical Soaking of Tranexamic Acid (TXA), or Placebo in Femoral Neck Fractured Patients Undergoing Cementless Bipolar Hemiarthroplasty

K

King Chulalongkorn Memorial Hospital

Status

Enrolling

Conditions

Femoral Neck Fracture

Treatments

Drug: Topical tranexamic acid administration

Study type

Interventional

Funder types

Other

Identifiers

NCT06289478
0151/67

Details and patient eligibility

About

The goal of this Randomized controlled trial is to evaluate in household ambulatory, elderly patients sustaining femoral neck fracture who are subjected to be treat with cementless bipolar hemiarthroplasty. The main questions it aims to answer are:

  • The efficacy in reducing blood transfusion for topical tranexamic acid administration
  • The safety of tranexemic acid, topically used

As having undergone bipolar hemiarthroplasty surgery, participants will either receive retrograde intraarticular tranexamic acid injection via drain tube, or topical soaking administration.

Researchers will compare, with standard procedure (procedure), whether topically administered tranexamic acid would reduce rate of blood transfusion.

Enrollment

75 estimated patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Elderly patients (age > 60 years)
  • Femoral neck fractures from low energy mechanism
  • Household ambulator
  • Undergoing cementless bipolar hemiarthroplasty at KCMH
  • Informed consent

Exclusion criteria

  • Allergy to TXA
  • History of VTE
  • History of hip surgery, pathological fracture, hip infection
  • Congenital or acquired coagulopathy
  • Hb < 10 g/dL or Platelet < 140,000

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

75 participants in 3 patient groups, including a placebo group

Retrograde Intraarticular Injection via Drain Tube
Experimental group
Description:
Tranexamic acid will be injected retrograde to the joint via drain tube after surgical wound closure
Treatment:
Drug: Topical tranexamic acid administration
Topical Soaking of Tranexamic Acid
Experimental group
Description:
Tranexamic acid will be placed to soak the intramedullary canal of the femur and surgical area after sheath closure for 5 minutes and completely remove by sunction
Treatment:
Drug: Topical tranexamic acid administration
Standard procedure (placebo)
Placebo Comparator group
Description:
Standard wound irrigation
Treatment:
Drug: Topical tranexamic acid administration

Trial contacts and locations

2

Loading...

Central trial contact

Kanyakorn Riewruja, Medical degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems